GFFFX
Price
$66.00
Change
+$0.05 (+0.08%)
Updated
Apr 17 closing price
Net Assets
261.04B
TADCX
Price
$19.76
Change
+$0.01 (+0.05%)
Updated
Apr 17 closing price
Net Assets
2.2B
Ad is loading...

GFFFX vs TADCX

Header iconGFFFX vs TADCX Comparison
Open Charts GFFFX vs TADCXBanner chart's image
American Funds Growth Fund of Amer F2
Price$66.00
Change+$0.05 (+0.08%)
VolumeN/A
Net Assets261.04B
Transamerica US Growth C
Price$19.76
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets2.2B
GFFFX vs TADCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFFFX vs. TADCX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFFFX is a Buy and TADCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFFFX has more cash in the bank: 261B vs. TADCX (2.2B). GFFFX pays higher dividends than TADCX: GFFFX (0.62) vs TADCX (0.00). GFFFX was incepted earlier than TADCX: GFFFX (17 years) vs TADCX (15 years). TADCX (1.86) is less costly to investors than GFFFX (0.40). GFFFX has a lower initial minimum investment than TADCX: GFFFX (250) vs TADCX (1000). GFFFX annual gain was more profitable for investors over the last year : -2.64 vs. TADCX (-17.47). GFFFX return over 5 years is better than : 38.30 vs. TADCX (2.97).
GFFFXTADCXGFFFX / TADCX
Total Expense Ratio0.401.8622%
Annual Report Gross Expense Ratio0.401.8622%
Fund Existence17 years15 years-
Gain YTD-11.015-15.67070%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets261B2.2B11,842%
Annual Yield % from dividends0.620.00-
Returns for 1 year-2.64-17.4715%
Returns for 3 years5.76-8.65-67%
Returns for 5 years38.302.971,289%
Returns for 10 years49.0319.34254%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMYTX38.680.07
+0.18%
Putnam Core Equity Fund R6
RYRCX37.61N/A
N/A
Rydex Retailing C
LMOFX32.40N/A
N/A
Patient Opportunity FI
CMCRX37.13N/A
N/A
Calvert US Mid Cap Core Rspnb Idx R6
SSIPX11.70N/A
N/A
State Street International Stock Sel I